Page 45 - 68_02
P. 45
E. BARCIA S. NEGRO ANAL REAL ACAD. NAC. FARM
(13) TSUTSUMI, E., FUJIKI, H., FUKUSHIMA, H. (1979): Effect of furosemide on serum
clearance and renal excretion of digoxin. J. Clin. Pharmacol. 19:200.
(14) JORGENSON, A.W., SORENSEN, O.H. (1970): Digitalis intoxication: A comparative
study on the incidence of digitalis intoxication during the periods 1950-1952 and
1964-1966. Acta Med. Scand. 188:179.
(15) CASNER, P.R. (1996): Inability to attain oral anticoagulation: warfarin-rifampin
interaction revisited. South Med. J. 89:1200-1203.
(16) Avery´s Drug Treatment (1985). 3rd edition. Williams and Wilkins. Baltimore.
(17) HANSEN, M.M., KNUPP, C.A., PFEFFER, M., PITTMAN, K.A. (1977): Nephrotoxic-
ity in combined cephalothin and gentamicin therapy. Acta Med. Scand. 201:463-
467.
(18) TOBIAS, J.S., WHITEHOUSE, J.M., WRIGLEY, P.F. (1976). Severe renal dysfunction
after tobramycin/cephalothin therapy. Lancet. i:425.
(19) PEDERSEN, F.M., HAMBERG, O., HESS, K., OVESEN, L. (1991). The effect of die-
tary vitamin K on warfarin-induced anticoagulation. J. Intern. Med. 229:517-520.
(20) SHARGEL, L., YU, A.B.C. (1995). Applied biopharmaceutics and pharmacokinet-
ics. 3rd edition. Appleton Lange. Norwalk.
(21) ROWLAND, M. (1995). Clinical pharmacokinetics: concepts and applications. 3rd
ed. Lea & Febiger. Baltimore.
(22) DOMÉNECH BERROZPE, J., MARTÍNEZ LANAO, J., PLÁ DELFINA, J.M. eds.(1998).
Biofarmacia y farmacocinética. Volumen II: Biofarmacia. Editorial Síntesis, S.A.
Madrid.
(23) BARCIA HERNÁNDEZ, E., NEGRO ALVAREZ, S. COORDS.(2001). Curso de interac-
ciones de los medicamentos. Fundación de Estudios y Formación Sanitaria. Vigo.
(24) CADÓRNIGA CARRO, R. (1999). Interacciones medicamentosas (y otros factores
modificadores de la respuesta). Fundación S.B. Madrid.
(25) KNUPP, C.A., DIXON, R.M., GRACIANO, F., DUNKLE, L.M:, BARBHAIYA, R.H.
(1992): Pharmacokinetic interaction study of didanosine and ranitidine in patients
seropositive for human immunodeficiency virus. Antimicrob. Ag. Chemother.
36:2975-2079.
(26) BARRY, M., GIBBONS, S., BACK, D. (1997): Protease inhibitors in patients with
HIV disease. Clin. Pharmacokinet. 32(3):194-209.
(27) NOBLE, S., FAULDS, D. (1996):; Saquinavir: a review of its pharmacology and
clinical potential in the management of HIV infection. Drugs. 52:93-112.
(28) KIVISTO, K.T., LEHTO, P., NEUVONEN, P.J. (1993): The effects of different doses
of sodium bicarbonate on the absorption and activity of non-micronized gliben-
clamide. Int. J. Clin. Pharmacol. Ther. Toxicol. 31:236-240.
(29) BLUM, R.A., D´ANDREA, D.T., FLORENTINO, B.M., WILTON, J.H., HILLIGOSS,
D.M., GARDNER, M.J., HENRY, E.B., GOLDSTEIN, H., ACHENTAG, J.J. (1991): In-
168
